TRANSGENIC MOUSE MODEL FOR TOLERANCE IN THE EYE
眼部耐受性转基因小鼠模型
基本信息
- 批准号:2163315
- 负责人:
- 金额:$ 21.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-12-01 至 1996-11-30
- 项目状态:已结题
- 来源:
- 关键词:MHC class I antigen MHC class II antigen T lymphocyte age difference autoimmune disorder crystallins disease /disorder model flow cytometry fusion gene gene expression genetically modified animals histocompatibility antigens immune tolerance /unresponsiveness immunocytochemistry immunogenetics inflammation interferon gamma isoantigen laboratory mouse lens model design /development monoclonal antibody tissue /cell culture uveitis
项目摘要
A central question in the understanding of autoimmune disease processes
is how T cell tolerance is developed and maintained to self antigens.
Tolerance to self-antigens is acquired in the thymus through a process
termed negative selection, and in the allogeneic MHC or foreign antigens
are expressed only in extrathymic tissues have provided considerable
insight into the mechanisms of peripheral tolerance induction, but still
many questions remain. We have developed a new transgenic model for
tolerance in which an allogeneic mcH antigen or IFn-gamma is expressed
in the lens of the eyes, an immunologically privileged site. The lens
of the eye represents and excellent model for further study of peripheral
tolerance for several reasons. It lacks vascularization and lymphatic
drainage Thus, this site may have unique properties concerning tolerance
induction. The eye is also a prominent target in several autoimmune
diseases including HLA-B27 linked Reiter's syndrome. In order to study
tolerance induction to antigens expressed in the lens, transgenic mice
have been produced expressing MHC class I (H-2D) or interferon gamma
under expression and appear to be promising models for tolerance studies.
These models will be immunohistochemistry. Experiments will also
determine whether the H-2D antigen expressed in the lens is associated
with Beta 2-microglobulin. The inflammatory changes taking place in
these mice will be carefully evaluated histologically at different ages.
Experiments are also proposed to test whether these changes are
immunologically mediated. For the class I transgenic mice, we will
assess the degree of tolerance to the allo class I transgenic in both in
vitro and in vivo systems. For the INF-gamma transgenic mice, we will
determine whether specific T cell sensitization to ocular antigens is
occurring and whether IFN-gamma expression in the eye modifies the
immunosuppressive nature of the eye. Finally, we propose to produce a
third model by expressing I-E antigens under the control of the alpha-A
crystallin promoter. In these mice, clonal deletion of Vbeta17a (I-E
reactive) T cells will be assessed by monoclonal antibody staining and
flow cytometry. These studies will provide important new information on
the mechanisms of tolerance induction to tissue restricted antigens, and
provide new mouse models for autoimmune uveitis.
了解自身免疫性疾病过程的一个中心问题
T细胞对自身抗原的耐受性是如何形成和维持的。
对自身抗原的耐受性是通过一个过程在胸腺中获得的。
在同种异体MHC或外源抗原中,
仅在胸腺外组织中表达,
深入了解外周耐受诱导的机制,但仍然
许多问题仍然存在。 我们开发了一种新的转基因模型,
表达同种异体mcH抗原或IFN-γ的耐受性
在眼睛的透镜中,一个免疫特权部位。 该透镜
的眼睛代表和良好的模型,为进一步研究周边
宽容有几个原因。 它缺乏血管和淋巴管
因此,这个网站可能有独特的属性有关的宽容
诱导 眼睛也是几种自身免疫性疾病的突出目标。
包括HLA-B27相关的赖特综合征。 为了研究
对透镜中表达的抗原的耐受诱导,转基因小鼠
已经产生表达MHC I类(H-2D)或干扰素γ的
在表达下,似乎是耐受性研究的有前途的模型。
这些模型将进行免疫组织化学。 实验也将
确定透镜中表达的H-2D抗原是否相关
β 2微球蛋白 炎症变化发生在
将在不同年龄对这些小鼠进行仔细的组织学评价。
实验也提出了测试这些变化是否是
免疫介导的 对于I类转基因小鼠,我们将
评估在两种情况下对异源I类转基因的耐受程度,
体外和体内系统。 对于INF-γ转基因小鼠,
确定是否特异性T细胞致敏眼抗原,
发生以及眼睛中IFN-γ的表达是否改变了
眼睛的免疫抑制性质。 最后,我们建议制作一个
第三种模型,通过在α-A的控制下表达I-E抗原
晶体蛋白启动子 在这些小鼠中,克隆缺失V β 17 a(I-E
通过单克隆抗体染色评估T细胞,
流式细胞仪 这些研究将提供重要的新信息,
对组织限制性抗原的耐受诱导机制,以及
为自身免疫性葡萄膜炎提供新的小鼠模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jerold G Woodward其他文献
Unfolded Von Willebrand Factor Interacts with Protein S and Limits Its Anticoagulant Activity
- DOI:
10.1182/blood-2022-162612 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Martha MS Sim;Hammodah Alfar;Melissa Hollifield;Dominic W. Chung;Xiaoyun Fu;Meenakshi Banerjee;Chi Peng;Xian Li;Alice Thornton;James Z Porterfield;Jamie Sturgill;Gail A Sievert;Marietta Barton-Baxter;Kenneth S Campbell;Jerold G Woodward;José A. López;Sidney W Whiteheart;Beth A Garvy;Jeremy P Wood - 通讯作者:
Jeremy P Wood
Jerold G Woodward的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jerold G Woodward', 18)}}的其他基金
Chylomicrons promote intestinal absorption and systemic dissemination of dietary
乳糜微粒促进肠道吸收和膳食的全身传播
- 批准号:
8053458 - 财政年份:2010
- 资助金额:
$ 21.87万 - 项目类别:
To produce transgenic mice which express T cell receptors specific for (IRBP).
产生表达特异T细胞受体(IRBP)的转基因小鼠。
- 批准号:
7535963 - 财政年份:2008
- 资助金额:
$ 21.87万 - 项目类别:
To produce transgenic mice which express T cell receptors specific for (IRBP).
产生表达特异T细胞受体(IRBP)的转基因小鼠。
- 批准号:
7675985 - 财政年份:2008
- 资助金额:
$ 21.87万 - 项目类别:
相似海外基金
MHC class II antigen presentation in melanoma: impact on immune recognition
黑色素瘤中 MHC II 类抗原呈递:对免疫识别的影响
- 批准号:
10618790 - 财政年份:2021
- 资助金额:
$ 21.87万 - 项目类别:
MHC class II antigen presentation in melanoma: impact on immune recognition
黑色素瘤中 MHC II 类抗原呈递:对免疫识别的影响
- 批准号:
10392325 - 财政年份:2021
- 资助金额:
$ 21.87万 - 项目类别:
MHC Class II Antigen Presentation In Melanoma: Impact on Immune Recognition
黑色素瘤中 MHC II 类抗原的呈现:对免疫识别的影响
- 批准号:
10674177 - 财政年份:2021
- 资助金额:
$ 21.87万 - 项目类别:
VARIATION IN MHC CLASS II ANTIGEN BINDING SITE OF ATLANTIC SALMON, SALMO SALAR
大西洋鲑鱼 SALMO SALAR MHC II 类抗原结合位点的变异
- 批准号:
8360306 - 财政年份:2011
- 资助金额:
$ 21.87万 - 项目类别:
VARIATION IN MHC CLASS II ANTIGEN BINDING SITE OF ATLANTIC SALMON, SALMO SALAR
大西洋鲑鱼 SALMO SALAR MHC II 类抗原结合位点的变异
- 批准号:
8167705 - 财政年份:2010
- 资助金额:
$ 21.87万 - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
8131116 - 财政年份:2007
- 资助金额:
$ 21.87万 - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
7321929 - 财政年份:2007
- 资助金额:
$ 21.87万 - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
7673392 - 财政年份:2007
- 资助金额:
$ 21.87万 - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
7483748 - 财政年份:2007
- 资助金额:
$ 21.87万 - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
7907767 - 财政年份:2007
- 资助金额:
$ 21.87万 - 项目类别:














{{item.name}}会员




